Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of HLX10 plus carboplatin + nab-paclitaxel as first-line treatment for advanced or metastatic squamous non-small cell lung cancer
CTR20190907Phase 3Active
- Sponsor
- HyBioPharma
- Start
- Aug 2019
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of serplulimab in Pulmonary squamous cell carcinoma, sponsored by HyBioPharma. Started Aug 2019; status: active.
02
Drugs
serplulimab
03
Conditions
Pulmonary squamous cell carcinoma
Beyond the preview
Go deeper on CTR20190907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190907.